Natus Medical Inc (BABY) 36.39 $BABY
Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 36.39 (-0.32), MASI: 52.10 (-0.32), EXAC: 25.42 (+0.12), CRY: 11.88 (-0.10)
Natus Announces $20 Million Share Repurchase Program
GlobeNewswire - Fri Jun 03, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) announced that its Board of Directors has approved an expansion of its existing stock repurchase program, authorizing the repurchase of up to an additional $20 million of the Company's common stock. The expiration date is set for June 1, 2017.
BABY: 36.39 (-0.32)
Natus to Present at Jefferies 2016 Healthcare Conference
GlobeNewswire - Wed Jun 01, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York City. Mr. Hawkins is scheduled to present at 3:30 p.m. EDT on Thursday, June 9, 2016.
BABY: 36.39 (-0.32)
Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc.
PR Newswire - Mon May 09, 7:47PM CDT
Amaya, Inc. (AYA)
BABY: 36.39 (-0.32), RUN: 6.30 (-0.13), XON: 25.27 (+0.14), AYA: 15.06 (-0.19), VSLR: 3.19 (-0.09), TRXC: 1.45 (+0.01), NYLD: 15.82 (-0.76), CHMA: 2.91 (-0.23)
Natus to Present at UBS Global Healthcare Conference
GlobeNewswire - Mon May 09, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York, NY. Mr. Kennedy is scheduled to present on Tuesday, May 24 at 10:00 a.m. Eastern Time (7:00 a.m. PT).
BABY: 36.39 (-0.32)
ATTENTION NATUS SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Natus Medical Incorporated; Encourages Investors to Contact the Firm for Additional Information
PR Newswire - Fri Apr 22, 8:30PM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Natus Medical Incorporated (NASDAQ: BABY) and certain of its officers. Natus designs, manufactures and markets newborn care and neurology healthcare products and services worldwide.
BABY: 36.39 (-0.32)
Hagens Berman Investigates Natus Medical Inc.'s Guidance on Prepayments From the Venezuelan Government and the Timing of Insider Sales
BusinessWire - Fri Apr 22, 7:30AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating whether Natus Medical Incorporated. (NASDAQ: BABY) issued false and misleading statements about its expected receipt of prepayments under a contract with the Venezuelan Government and the timing of certain insiders' stock sales, potentially in violation of the securities laws.
BABY: 36.39 (-0.32)
Natus Medical Inc Says Adios to Venezuela Guidance
Brian Orelli, The Motley Fool - Motley Fool - Wed Apr 20, 3:05PM CDT
Natus Medical reported revenue of $87.3 million in the first quarter, just shy of the preliminary number of "approximately $87.5 million" that was disclosed earlier this month when the company said it wasn't going to hit its guidance. That's a...
BABY: 36.39 (-0.32)
Natus Medical beats 1Q profit forecasts
Automated Insights - Wed Apr 20, 5:11AM CDT
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported first-quarter profit of $8.5 million.
BABY: 36.39 (-0.32)
Natus Medical Announces Record First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 20, 5:00AM CDT
-- Record first quarter non-GAAP earnings per share of $0.34
BABY: 36.39 (-0.32)
3 Things to Watch as Natus Medical Inc Reports Earnings
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 18, 3:15PM CDT
Image source: Natus Medical. Like the previous quarter, Natus Medical 's top-line results for the first quarter are going to be unsurprising when the company reports earnings on Wednesday since the revenue number was already disclosed . In...
BABY: 36.39 (-0.32)
NATUS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Natus Medical Inc. to Contact the Firm
BusinessWire - Fri Apr 15, 7:18PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Natus Medical Inc. ("Natus" or the "Company"
(NASDAQ:BABY).
BABY: 36.39 (-0.32)
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Natus Medical Inc. and Advises Investors with Losses to Contact the Firm
BusinessWire - Fri Apr 15, 4:02PM CDT
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Natus Medical Inc. ("Natus" or the "Company" (Nasdaq: BABY). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
BABY: 36.39 (-0.32)
INVESTOR ALERT: Investigation of Natus Medical Inc. Announced by Law Offices of Howard G. Smith
BusinessWire - Fri Apr 15, 12:13PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Natus Medical Inc. ("Natus" or the "Company" (NASDAQ: BABY) concerning the Company and its officers' possible violations of federal securities laws. Law Offices of Howard G. Smith is preparing a lawsuit on behalf of injured investors.
BABY: 36.39 (-0.32)
Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 36.39 (-0.32), GMED: 24.63 (-0.54), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)
Downgrade Alert for Natus Medical (BABY)
Comtex SmarTrend(R) - Wed Apr 06, 3:24AM CDT
Natus Medical (NASDAQ:BABY) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $29.68 on volume of 1.8 million shares, above average daily volume of 322,000. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. The Company's products identify and monitor common medical disorders that may occur between conception to a baby's first birthday. Natus is selling its ALGO products for newborn hearing screening, as well as its CO-Stat products for the evaluation of jaundice.
BABY: 36.39 (-0.32)
Company News for April 05, 2016
Zacks Equity Research - Zacks Investment Research - Tue Apr 05, 9:10AM CDT
Companies in the News are: VA,ALK,BABY,PHM,YHOO,TIME,SFTBF
TIME: 16.68 (-0.29), YHOO: 36.83 (-0.52), BABY: 36.39 (-0.32), VA: 56.02 (-0.09), PHM: 19.22 (-0.36), ALK: 66.92 (-0.58)
Virgin America and Edwards rise; Brocade, PulteGroup fall
AP - Mon Apr 04, 3:37PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq stock market:
BABY: 36.39 (-0.32), TSLA: 218.79 (-10.57), VA: 56.02 (-0.09), EW: 101.52 (-0.96), BRCD: 8.87 (-0.10)
Natus Medical Announces Preliminary Revenue for the First Quarter 2016
GlobeNewswire - Mon Apr 04, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced preliminary revenue for is first quarter ended March 31, 2016.
BABY: 36.39 (-0.32)
Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 36.39 (-0.32), MASI: 52.10 (-0.32), EXAC: 25.42 (+0.12), CRY: 11.88 (-0.10)
Natus Announces $20 Million Share Repurchase Program
GlobeNewswire - Fri Jun 03, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) announced that its Board of Directors has approved an expansion of its existing stock repurchase program, authorizing the repurchase of up to an additional $20 million of the Company's common stock. The expiration date is set for June 1, 2017.
BABY: 36.39 (-0.32)
Natus to Present at Jefferies 2016 Healthcare Conference
GlobeNewswire - Wed Jun 01, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York City. Mr. Hawkins is scheduled to present at 3:30 p.m. EDT on Thursday, June 9, 2016.
BABY: 36.39 (-0.32)
Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc.
PR Newswire - Mon May 09, 7:47PM CDT
Amaya, Inc. (AYA)
BABY: 36.39 (-0.32), RUN: 6.30 (-0.13), XON: 25.27 (+0.14), AYA: 15.06 (-0.19), VSLR: 3.19 (-0.09), TRXC: 1.45 (+0.01), NYLD: 15.82 (-0.76), CHMA: 2.91 (-0.23)
Natus to Present at UBS Global Healthcare Conference
GlobeNewswire - Mon May 09, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York, NY. Mr. Kennedy is scheduled to present on Tuesday, May 24 at 10:00 a.m. Eastern Time (7:00 a.m. PT).
BABY: 36.39 (-0.32)
ATTENTION NATUS SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Natus Medical Incorporated; Encourages Investors to Contact the Firm for Additional Information
PR Newswire - Fri Apr 22, 8:30PM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Natus Medical Incorporated (NASDAQ: BABY) and certain of its officers. Natus designs, manufactures and markets newborn care and neurology healthcare products and services worldwide.
BABY: 36.39 (-0.32)
Hagens Berman Investigates Natus Medical Inc.'s Guidance on Prepayments From the Venezuelan Government and the Timing of Insider Sales
BusinessWire - Fri Apr 22, 7:30AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating whether Natus Medical Incorporated. (NASDAQ: BABY) issued false and misleading statements about its expected receipt of prepayments under a contract with the Venezuelan Government and the timing of certain insiders' stock sales, potentially in violation of the securities laws.
BABY: 36.39 (-0.32)
Natus Medical Inc Says Adios to Venezuela Guidance
Brian Orelli, The Motley Fool - Motley Fool - Wed Apr 20, 3:05PM CDT
Natus Medical reported revenue of $87.3 million in the first quarter, just shy of the preliminary number of "approximately $87.5 million" that was disclosed earlier this month when the company said it wasn't going to hit its guidance. That's a...
BABY: 36.39 (-0.32)
Natus Medical beats 1Q profit forecasts
Automated Insights - Wed Apr 20, 5:11AM CDT
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported first-quarter profit of $8.5 million.
BABY: 36.39 (-0.32)
Natus Medical Announces Record First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 20, 5:00AM CDT
-- Record first quarter non-GAAP earnings per share of $0.34
BABY: 36.39 (-0.32)
3 Things to Watch as Natus Medical Inc Reports Earnings
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 18, 3:15PM CDT
Image source: Natus Medical. Like the previous quarter, Natus Medical 's top-line results for the first quarter are going to be unsurprising when the company reports earnings on Wednesday since the revenue number was already disclosed . In...
BABY: 36.39 (-0.32)
NATUS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Natus Medical Inc. to Contact the Firm
BusinessWire - Fri Apr 15, 7:18PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Natus Medical Inc. ("Natus" or the "Company"
(NASDAQ:BABY). BABY: 36.39 (-0.32)
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Natus Medical Inc. and Advises Investors with Losses to Contact the Firm
BusinessWire - Fri Apr 15, 4:02PM CDT
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Natus Medical Inc. ("Natus" or the "Company"
(Nasdaq: BABY). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors. BABY: 36.39 (-0.32)
INVESTOR ALERT: Investigation of Natus Medical Inc. Announced by Law Offices of Howard G. Smith
BusinessWire - Fri Apr 15, 12:13PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Natus Medical Inc. ("Natus" or the "Company"
(NASDAQ: BABY) concerning the Company and its officers' possible violations of federal securities laws. Law Offices of Howard G. Smith is preparing a lawsuit on behalf of injured investors. BABY: 36.39 (-0.32)
Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 36.39 (-0.32), GMED: 24.63 (-0.54), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)
Downgrade Alert for Natus Medical (BABY)
Comtex SmarTrend(R) - Wed Apr 06, 3:24AM CDT
Natus Medical (NASDAQ:BABY) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $29.68 on volume of 1.8 million shares, above average daily volume of 322,000. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. The Company's products identify and monitor common medical disorders that may occur between conception to a baby's first birthday. Natus is selling its ALGO products for newborn hearing screening, as well as its CO-Stat products for the evaluation of jaundice.
BABY: 36.39 (-0.32)
Company News for April 05, 2016
Zacks Equity Research - Zacks Investment Research - Tue Apr 05, 9:10AM CDT
Companies in the News are: VA,ALK,BABY,PHM,YHOO,TIME,SFTBF
TIME: 16.68 (-0.29), YHOO: 36.83 (-0.52), BABY: 36.39 (-0.32), VA: 56.02 (-0.09), PHM: 19.22 (-0.36), ALK: 66.92 (-0.58)
Virgin America and Edwards rise; Brocade, PulteGroup fall
AP - Mon Apr 04, 3:37PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq stock market:
BABY: 36.39 (-0.32), TSLA: 218.79 (-10.57), VA: 56.02 (-0.09), EW: 101.52 (-0.96), BRCD: 8.87 (-0.10)
Natus Medical Announces Preliminary Revenue for the First Quarter 2016
GlobeNewswire - Mon Apr 04, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced preliminary revenue for is first quarter ended March 31, 2016.
BABY: 36.39 (-0.32)
